NCT03895034View on ClinicalTrials.gov

Exploratory Study to Evaluate the Use of the RxSight Light Adjustable Lens (LAL) and the Light Delivery Device (LDD) to Improve Visual Outcomes

CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

June 14, 2018

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2020

Conditions
AphakiaCataract
Interventions
DEVICE

Light Adjustable lens (LAL) and Light Delivery Device (LDD)

Eligible eyes will receive Light adjustable lens with Light delivery Device treatments

Trial Locations (1)

Unknown

CODET Vision Institute, Tijuana

All Listed Sponsors
lead

RxSight, Inc.

INDUSTRY

NCT03895034 - Exploratory Study to Evaluate the Use of the RxSight Light Adjustable Lens (LAL) and the Light Delivery Device (LDD) to Improve Visual Outcomes | Biotech Hunter | Biotech Hunter